Oncotarget Novel Triple-Drug Combination to Fight Pancreatic Cancer In this new study, researchers unveiled a promising synergistic strategy for combating pancreatic cancer.—In... read more July 25, 2024
Oncotarget Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer In this editorial, researchers delve into the immunotherapeutic challenges posed by the tumor microenvironment and... read more November 16, 2023
Oncotarget Controlling Glycolytic Flux: Therapy Challenges and Solutions In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more February 16, 2023
Oncotarget Could Metformin and Rapamycin Replace Maintenance Chemotherapy? Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic... read more December 16, 2021
Oncotarget New Study: How Worms Can Detect Early Pancreatic Cancer Researchers from Japan used Caenorhabditis elegans (a one millimeter roundworm) to detect early pancreatic ductal... read more August 18, 2021
Oncotarget Table of Contents: Oncotarget’s Volume 12, Issue #16 Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more August 3, 2021
Oncotarget Behind the Study: miRNA-185 Emerges as Regulator of KRAS Harvard Medical School Professor Frank Slack discusses his 2016 study published in Oncotarget, entitled, “Cis-acting... read more April 18, 2021
Oncotarget Behind the Study: Phenanthrene and Human Pancreatic Cancer Cells Senior researcher, Professor Malka Cohen-Armon, describes the study she co-authored in Oncotarget entitled, “The phenanthrene... read more March 15, 2021
Oncotarget Novel Study Urges Researchers to Study Pancreatic Cancer in a New Way In this study, researchers performed the first comprehensive analysis of the current landscape of clinical... read more October 1, 2020